Extended Data Table 3 Demographic and disease characteristics at baseline

From: The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer

  1. The treatment regimen included trastuzumab and chemotherapy in both groups.
Back to article page